Patients with follow up: | 70 |
---|---|
Female: male | 58:12 (females 83% - males 17%) |
Mean age at the visit | 14.2 ± 2.4 |
Mean age at migraine onset | 11.2 ± 3.2 |
Mean age at chronification onset | 13.6 ± 2.3 |
High- frequency migraine before chronification (%) | n = 61 (87%) |
Preventative treatment before chronification (%) | n = 20 (28.5%) |
Acute Medication tried before (%) | Paracetamol n = 41 (58.6%) NSAIDs n = 56 (80%) Triptan n = 1 (1.4%) |
Responder vs. Non Responder Baseline (%) | n = 19/70 vs. n = 51/70 (27% vs. 73%) |
Responder vs. Non Responder After preventive (%) | n = 41/58 vs. n = 17/58 (71.4% vs. 28.6%) |
MOH MOH in Responder vs. Non Responder % | n = 19/70 (27.1%) 22% vs. 27% |
Neuropsychiatric comorbidities Neuropsychiatric comorbidities in Responder vs. Non Responder % | n = 48/70 (69%) 72.2% vs. 67.3% |